Cargando…
Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications
Structural cardiac lesions are often surgically repaired using prosthetic patches, which can be biological or synthetic. In the current clinical scenario, biological patches derived from the decellularization of a xenogeneic scaffold are gaining more interest as they maintain the natural architectur...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792098/ https://www.ncbi.nlm.nih.gov/pubmed/36578513 http://dx.doi.org/10.3389/fbioe.2022.1042434 |
_version_ | 1784859560187527168 |
---|---|
author | Palmosi, Tiziana Tolomeo, Anna Maria Cirillo, Carmine Sandrin, Debora Sciro, Manuela Negrisolo, Susanna Todesco, Martina Caicci, Federico Santoro, Michele Dal Lago, Eleonora Marchesan, Massimo Modesti, Michele Bagno, Andrea Romanato, Filippo Grumati, Paolo Fabozzo, Assunta Gerosa, Gino |
author_facet | Palmosi, Tiziana Tolomeo, Anna Maria Cirillo, Carmine Sandrin, Debora Sciro, Manuela Negrisolo, Susanna Todesco, Martina Caicci, Federico Santoro, Michele Dal Lago, Eleonora Marchesan, Massimo Modesti, Michele Bagno, Andrea Romanato, Filippo Grumati, Paolo Fabozzo, Assunta Gerosa, Gino |
author_sort | Palmosi, Tiziana |
collection | PubMed |
description | Structural cardiac lesions are often surgically repaired using prosthetic patches, which can be biological or synthetic. In the current clinical scenario, biological patches derived from the decellularization of a xenogeneic scaffold are gaining more interest as they maintain the natural architecture of the extracellular matrix (ECM) after the removal of the native cells and remnants. Once implanted in the host, these patches can induce tissue regeneration and repair, encouraging angiogenesis, migration, proliferation, and host cell differentiation. Lastly, decellularized xenogeneic patches undergo cell repopulation, thus reducing host immuno-mediated response against the graft and preventing device failure. Porcine small intestinal submucosa (pSIS) showed such properties in alternative clinical scenarios. Specifically, the US FDA approved its use in humans for urogenital procedures such as hernia repair, cystoplasties, ureteral reconstructions, stress incontinence, Peyronie’s disease, penile chordee, and even urethral reconstruction for hypospadias and strictures. In addition, it has also been successfully used for skeletal muscle tissue reconstruction in young patients. However, for cardiovascular applications, the results are controversial. In this study, we aimed to validate our decellularization protocol for SIS, which is based on the use of Tergitol 15 S 9, by comparing it to our previous and efficient method (Triton X 100), which is not more available in the market. For both treatments, we evaluated the preservation of the ECM ultrastructure, biomechanical features, biocompatibility, and final bioinductive capabilities. The overall analysis shows that the SIS tissue is macroscopically distinguishable into two regions, one smooth and one wrinkle, equivalent to the ultrastructure and biochemical and proteomic profile. Furthermore, Tergitol 15 S 9 treatment does not modify tissue biomechanics, resulting in comparable to the native one and confirming the superior preservation of the collagen fibers. In summary, the present study showed that the SIS decellularized with Tergitol 15 S 9 guarantees higher performances, compared to the Triton X 100 method, in all the explored fields and for both SIS regions: smooth and wrinkle. |
format | Online Article Text |
id | pubmed-9792098 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97920982022-12-27 Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications Palmosi, Tiziana Tolomeo, Anna Maria Cirillo, Carmine Sandrin, Debora Sciro, Manuela Negrisolo, Susanna Todesco, Martina Caicci, Federico Santoro, Michele Dal Lago, Eleonora Marchesan, Massimo Modesti, Michele Bagno, Andrea Romanato, Filippo Grumati, Paolo Fabozzo, Assunta Gerosa, Gino Front Bioeng Biotechnol Bioengineering and Biotechnology Structural cardiac lesions are often surgically repaired using prosthetic patches, which can be biological or synthetic. In the current clinical scenario, biological patches derived from the decellularization of a xenogeneic scaffold are gaining more interest as they maintain the natural architecture of the extracellular matrix (ECM) after the removal of the native cells and remnants. Once implanted in the host, these patches can induce tissue regeneration and repair, encouraging angiogenesis, migration, proliferation, and host cell differentiation. Lastly, decellularized xenogeneic patches undergo cell repopulation, thus reducing host immuno-mediated response against the graft and preventing device failure. Porcine small intestinal submucosa (pSIS) showed such properties in alternative clinical scenarios. Specifically, the US FDA approved its use in humans for urogenital procedures such as hernia repair, cystoplasties, ureteral reconstructions, stress incontinence, Peyronie’s disease, penile chordee, and even urethral reconstruction for hypospadias and strictures. In addition, it has also been successfully used for skeletal muscle tissue reconstruction in young patients. However, for cardiovascular applications, the results are controversial. In this study, we aimed to validate our decellularization protocol for SIS, which is based on the use of Tergitol 15 S 9, by comparing it to our previous and efficient method (Triton X 100), which is not more available in the market. For both treatments, we evaluated the preservation of the ECM ultrastructure, biomechanical features, biocompatibility, and final bioinductive capabilities. The overall analysis shows that the SIS tissue is macroscopically distinguishable into two regions, one smooth and one wrinkle, equivalent to the ultrastructure and biochemical and proteomic profile. Furthermore, Tergitol 15 S 9 treatment does not modify tissue biomechanics, resulting in comparable to the native one and confirming the superior preservation of the collagen fibers. In summary, the present study showed that the SIS decellularized with Tergitol 15 S 9 guarantees higher performances, compared to the Triton X 100 method, in all the explored fields and for both SIS regions: smooth and wrinkle. Frontiers Media S.A. 2022-12-12 /pmc/articles/PMC9792098/ /pubmed/36578513 http://dx.doi.org/10.3389/fbioe.2022.1042434 Text en Copyright © 2022 Palmosi, Tolomeo, Cirillo, Sandrin, Sciro, Negrisolo, Todesco, Caicci, Santoro, Dal Lago, Marchesan, Modesti, Bagno, Romanato, Grumati, Fabozzo and Gerosa. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Palmosi, Tiziana Tolomeo, Anna Maria Cirillo, Carmine Sandrin, Debora Sciro, Manuela Negrisolo, Susanna Todesco, Martina Caicci, Federico Santoro, Michele Dal Lago, Eleonora Marchesan, Massimo Modesti, Michele Bagno, Andrea Romanato, Filippo Grumati, Paolo Fabozzo, Assunta Gerosa, Gino Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications |
title | Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications |
title_full | Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications |
title_fullStr | Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications |
title_full_unstemmed | Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications |
title_short | Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications |
title_sort | small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792098/ https://www.ncbi.nlm.nih.gov/pubmed/36578513 http://dx.doi.org/10.3389/fbioe.2022.1042434 |
work_keys_str_mv | AT palmositiziana smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications AT tolomeoannamaria smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications AT cirillocarmine smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications AT sandrindebora smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications AT sciromanuela smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications AT negrisolosusanna smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications AT todescomartina smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications AT caiccifederico smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications AT santoromichele smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications AT dallagoeleonora smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications AT marchesanmassimo smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications AT modestimichele smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications AT bagnoandrea smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications AT romanatofilippo smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications AT grumatipaolo smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications AT fabozzoassunta smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications AT gerosagino smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications |